Genes 2Me Private Limited - Due diligence report

A 360° intelligence report on Genes2Me Llc: trust score, financial health, credit view, compliance, directors, growth and distress signals -…

2019-08-23 Delhi, Delhi Active Unlisted
Connect MCP
G2 Genes 2Me Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genes2Me Llc — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Genes2Me Llc is assessed as Low Risk with a Trust Score of 88/100. Genes2Me Llc is an active private limited indian non-government company incorporated in 2019, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Genes 2Me Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (33.85 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
The Hongkong And Shanghai Banking Corporation Limited1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NEERAJ GUPTA 01234567 Director 01/04/2018 6 yrs Approved
RITU GUPTA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 3 year(s).
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 33.85 cr already registered.
  • Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2025
Last AGM held
Annual general meeting
28 Jul 2025
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 3.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
12 Sep 2022
Charge created
State Bank Of India - 29.75 cr
18 Aug 2022
Charge created
Hdfc Bank Limited - 1.10 cr
01 Apr 2021
Securities allotted
900000 Equity Shares Without Differential Rights - 90.00 Lakh raised
31 Mar 2020
Securities allotted
10000 Equity Shares Without Differential Rights - 1.00 Lakh raised
23 Aug 2019
Incorporated
Registered with Roc Delhi
Director appointed
NEERAJ GUPTA (Director)
Director appointed
RITU GUPTA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 3 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Informa Exhibitions India Private Limited U92490DL2004PTC124343 New Delhi, Delhi, India
Pilotsmith (India) Private Limited U28939TN2005PTC057413 Periamet, Tamil Nadu, India
Nupay U74999DL2018PTC335020 New Delhi, Delhi, India
Param Renewable Energy Private Limited U74999GJ2019PTC105888 Ahmadabad City, Gujarat, India
Tiket International Network Private Limited U72900DL2021FTC388586 New Delhi, Delhi, India
George Clinical U73100KA2012FTC080639 Bangalore North, Karnataka, India
Sgs Weather & Environmental Systems Private Limited U74999HR2003PTC079154 Gurugram, Haryana, India
Accuray U33111HR2007PTC042961 Shivaji Nagar, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genes2Me Llc before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genes2Me Llc: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Genes2Me Llc - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Genes2Me Llc pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genes2Me Llc - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genes2Me Llc an active company?

Genes2Me Llc has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Genes2Me Llc financially healthy?

Genes2Me Llc has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Genes2Me Llc?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genes2Me Llc?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Genes2Me Llc have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Genes2Me Llc up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Genes2Me Llc?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.